GlobeNewswire by notified

Christopher Ashworth appointed new President of FLSmidth Cement

Share

PRESS RELEASE
23 October 2023, Copenhagen, Denmark


Effective immediately, Christopher Ashworth has been appointed new President of FLSmidth Cement reporting to the Group CEO, Mikko Keto. This appointment follows the departure of the former President of FLSmidth Cement, Asger Lauritsen, in August 2023. During the interim period Group CFO, Roland M. Andersen, has in addition to his duties as Group CFO served as interim President of FLSmidth Cement.

Christopher brings a wealth of expertise from global industrial companies, having held various senior leadership positions. As a performance-driven leader with extensive experience in operational efficiency, customer satisfaction and portfolio transformation, he has a proven track record of executing transformative strategies for large industrial companies.

Christopher joins FLSmidth from Eurotherm, a Schneider-Electric company, where he for the last nine years has served as Vice President and Managing Director. During his tenure, he led the company through significant portfolio transformations and expansive restructuring efforts, resulting in strong top and bottom-line growth.

“I am pleased to have Christopher onboard. With his strong P&L management experience and broad industrial sector knowledge, I am confident that Christopher is the right leader for driving the continued transformation of our Cement business including the implementation of its pure play strategy. I also want to thank Roland for having successfully steered the Cement business during the interim period ensuring continued operations and focus on the long-term strategic goals”, comments Mikko Keto, Group CEO at FLSmidth.

Christopher Ashworth comments: “I look forward to driving the continued organisational transformation of FLSmidth Cement and to harness our core technologies and service offerings to facilitate the long-term green transition in the cement industry.”


Contacts:

Investor Relations
Jannick Lindegaard Denholt, +45 21 69 66 57, jli@flsmidth.com
Andreas Escherich Holkjær, +45 24 85 03 84, andh@flsmidth.com

Media Relations
Rasmus Windfeld, +45 40 44 60 60, rwin@flsmidth.com


About FLSmidth
FLSmidth is a full flowsheet technology and service supplier to the global mining and cement industries. We enable our customers to improve performance, lower operating costs and reduce environmental impact. MissionZero is our sustainability ambition towards zero emissions in mining and cement by 2030. FLSmidth works within fully validated Science-Based Targets, our commitment to keep global warming below 1.5°C and to becoming carbon neutral in our own operations by 2030. www.flsmidth.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Novotech Publishes Duchenne Muscular Dystrophy Landscape Report to Support Biotech Research Planning28.2.2024 07:32:56 CET | Press release

BOSTON, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today an industry-leading report on Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape. The report includes emerging genetic therapies, funding landscape, and a SWOT analysis designed to inform strategic drug development decision-making and ultimately enhancing the chances of successful and impactful treatments for DMD. The Novotech research analyst team provides these expert reports monthly, completely free of charge. These reports offer current insights into global clinical trial activity, revealing which regions experience the highest trial volumes and the factors behind these trends. They tackle the hurdles faced by biotech firms in specific therapeutic areas and discuss future paths in therapy and investment trends. The Duch

BW Energy: Fourth Quarter and Full Year Results 202328.2.2024 07:30:00 CET | Press release

FOURTH QUARTER AND FULL YEAR RESULTS 2023 HIGHLIGHTS Q4 EBITDA of USD 133.4 million and net profit of USD 80.2 millionFull-year revenue of USD 0.5 billion (+83%) with EBITDA of USD 241.0 million (+56%) and net profit of USD 81.0 million (+80%)Q4 gross production of 3.03 million barrels with 2.48 million net to BW EnergyFour liftings of 2.7 million barrels (net BWE) at average realised price of USD ~82 per barrelAchieved combined production milestone of 50,000 operated barrels per day in OctoberMaintained a strong balance sheet with cash position of USD 194 millionCompleted acquisition of FPSO Cidade de VitóriaDiscovery of Hibiscus SouthMoU signed with Cosco Shipping Heavy Industry for FPSO BW Maromba upgrade BW Energy, operator of the Dussafu Marin licence in Gabon and the Golfinho cluster offshore Brazil, reported EBITDA for the fourth quarter of 2023 of USD 133.4 million, up from USD 49.7 million in the third quarter of 2023, due to increased production and liftings. Gross production

Ageas reports full-year results 202328.2.2024 07:30:00 CET | Press release

Ageasreportsfull-yearresults 2023 Excellent commercial performance in Non-Life across all segments and double-digit growth in Life in ChinaNet Operating Result at EUR 1,166 million, reflected by an excellent Operational Capital GenerationCash position increased significantly to EUR 959 millionProposed total dividend of EUR 3.25 per share, up more than 8%. Final dividend of EUR 1.75 per share KeyFigures (Group)ResultNet Operating Result of EUR 1,166 million, representing a 16.2 %Return on EquityNet Result of EUR953 millionOperational Capital Generation of EUR1,803 millionOperational Free Capital Generation of EUR 1,162 millionInflows (at constant exchange rate)Inflows grew 8% at constant exchange rates, amounting to EUR 17.1 billion driven by the excellent commercial performance in Non-Life and strong sales in Life in ChinaLife inflows stood at EUR 11.2 billion with lower inflows in Belgium and Europe, compensated by growth in AsiaNon-Life inflows grew 17 % at constant exchange rates an

Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: results of IAP of takeover bid by TPG and reopening of the Offer on 28 February 202428.2.2024 07:30:00 CET | Press release

Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the results of the Initial Acceptance Period of the takeover bid by TPG and the reopening of the Offer on 28 February 2024. Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de resultaten van de Initiële Aanvaardingsperiode van het overnamebod van TPG en de heropening van het bod op 28 februari 2024. Chère Madame, Cher Monsieur, Veuillez trouver ci-dessous les liens vers le récent communiqué de presse d’Intervest Offices & Warehouses concernant les résultats de la période d’acceptation initiale de l’offre publique d’achat de TPG et la réouverture de l’offre le 28 février 2024. Attachments ENG_Intervest results IAPNL_Intervest results IAPFR_Intervest results IAP

Azerion publishes Interim Unaudited Financial Results Q4 2023 and Preliminary Unaudited Financial Results Full Year 202328.2.2024 07:15:00 CET | Press release

Platform growth and improved efficiency driving performance in Q4 Highlights of Q4 2023 Net revenue of € 171.8 million, up 15.5% from € 148.8 million in Q4 2022, mainly driven by Platform Segment growth, particularly in advertising revenue from Direct sales, e-commerce and previous acquisitions including Hawk. Adjusted EBITDA of € 25.9 million, up 17.2% from € 22.1 million in Q4 2022 with margins improved due to increased Platform Segment revenue and contribution from Direct sales, continued integration of previous acquisitions and ongoing cost optimisation. Platform segment Adjusted EBITDA, of € 22.3 million, up 26.0% compared to € 17.7 million in Q4 2022, reflecting increased Net revenue and Platform efficiencies from optimisation and consolidation efforts. Increased the average digital ads sold per month by over 20% to approximately 12.9 billion in Q4 2023, up from approximately 10.7 billion in Q4 2022, driven by the integration of past acquisitions and the increased cross-selling o

HiddenA line styled icon from Orion Icon Library.Eye